VCs shell out $39M for Complete Genomics

Proving once again how attractive DNA sequencing has become to investors, Mountain View, CA-based Complete Genomics reports that it has raised $39 million in a new venture round--its fifth. New investor Sands Capital led this round of financing and was joined by existing investors Essex Woodlands, OVP Venture Partners, Prospect Venture Partners, OrbiMed Advisors, Highland Capital and Enterprise Partners. "We continue to make strong business progress," boasted Complete Genomics CEO Cliff Reid in...

Complete Genomics maps plans for $86M IPO

One of the challengers in the race to revolutionize the field of gene sequencing with a low-cost set of lab tools has mapped out an $86.25 million IPO to test investors' appetite for the new technology. Mountain View, CA-based Complete Genomics plans to offer developers genome sequencing for less than $1,000, a price that would make the assembly-line technology available to virtually anyone looking to use it in development programs. As of last May, points out the San Jose Mercury...